Tag - Illumina

From Experimentation to Execution: How 2025 Reset the Trajectory of Healthcare and What 2026 Will Demand

Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company’s multiomics strategy

Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis

Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery

AGBT 2025 – And the Winner is, Drum Roll, Sequencing

2024 in Review

2023: Ozempic, 2nd Biggest Bank Collapse, AlphaFold, FDA Approval of Gene Therapy and CRISPR Gene Editing,….

L7 Informatics Manages and Supports the Entire Lab Workflow from Sample Processing to Data Analysis and Insight Generation Employing Workflow Orchestration

Changing the Clinical Genetic Testing Paradigm to Increase Sensitivity and Specificity

Broad Institute Launches $1K Sample-to-Report Clinical Whole-Genome Sequencing Service

Velsera Is Building an Ecosystem that Accelerates the R&D Loop and Democratizes Omics Data to Propel the Next Era of Precision Medicine

The Cheap Genome Is Not Enough – We Need an “Accurate and Good Genome”

2021 – Precision Medicine linked with Genomic Medicine: A Work in Progress

Rebus Bio Continues Expansion of Industry-leading Spatial Omics Platform with Breakthrough High-Plex Technology

Bionano Genomics Acquiring BioDiscovery – The Perfect Alignment of the Stars

Illumina and Genetic Alliance Launch $120 Million Global Initiative to Increase Equity and Improve Outcomes for Families Impacted by Genetic Disease

Copyright © 2026. enlighenbio LLC. All rights reserved.